343 related articles for article (PubMed ID: 25573984)
1. Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure.
López Mínguez JR; Asensio JM; Gragera JE; Costa M; González IC; de Carlos FG; Díaz JA; Martín Yuste V; González RM; Domínguez-Franco A; Buendía AB; Garibi JH; Hernández FH; Ribeiro VG
Heart; 2015 Jun; 101(11):877-83. PubMed ID: 25573984
[TBL] [Abstract][Full Text] [Related]
2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.
Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A
Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325
[TBL] [Abstract][Full Text] [Related]
5. Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry).
Lempereur M; Aminian A; Freixa X; Gafoor S; Shakir S; Omran H; Berti S; Santoro G; Kefer J; Landmesser U; Nielsen-Kudsk JE; Cruz-Gonzalez I; Kanagaratnam P; Nietlispach F; Ibrahim R; Sievert H; Schillinger W; Park JW; Gloekler S; Tzikas A
Am J Cardiol; 2017 Aug; 120(3):414-420. PubMed ID: 28595859
[TBL] [Abstract][Full Text] [Related]
6. Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation.
Berti S; Pastormerlo LE; Rezzaghi M; Trianni G; Paradossi U; Cerone E; Ravani M; De Caterina AR; Rizza A; Palmieri C
Heart; 2016 Dec; 102(24):1969-1973. PubMed ID: 27492943
[TBL] [Abstract][Full Text] [Related]
7. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II.
López-Mínguez JR; Nogales-Asensio JM; Infante De Oliveira E; De Gama Ribeiro V; Ruiz-Salmerón R; Arzamendi-Aizpurua D; Costa M; Gutiérrez-García H; Fernández-Díaz JA; Martín-Yuste V; Rama-Merchán JC; Moreno-Gómez R; Benedicto-Buendía A; Íñiguez-Romo A
Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):449-455. PubMed ID: 29754808
[TBL] [Abstract][Full Text] [Related]
8. Left atrial appendage occlusion: single center experience with PLAATO LAA Occlusion System(®) and AMPLATZER™ Cardiac Plug.
Helsen F; Nuyens D; De Meester P; Rega F; Budts W
J Cardiol; 2013 Jul; 62(1):44-9. PubMed ID: 23668912
[TBL] [Abstract][Full Text] [Related]
9. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug.
Santoro G; Meucci F; Stolcova M; Rezzaghi M; Mori F; Palmieri C; Paradossi U; Pastormerlo LE; Rosso G; Berti S
EuroIntervention; 2016 Feb; 11(10):1188-94. PubMed ID: 25354761
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit.
Gangireddy SR; Halperin JL; Fuster V; Reddy VY
Eur Heart J; 2012 Nov; 33(21):2700-8. PubMed ID: 23008509
[TBL] [Abstract][Full Text] [Related]
12. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
[TBL] [Abstract][Full Text] [Related]
13. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices.
Heeger CH; Rillig A; Lin T; Mathew S; Deiss S; Lemes C; Botros M; Metzner A; Wissner E; Kuck KH; Ouyang F; Tilz RR
Heart Rhythm; 2015 Jul; 12(7):1524-31. PubMed ID: 25769512
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.
Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z
Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528
[TBL] [Abstract][Full Text] [Related]
16. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous left atrial appendage closure for stroke prevention.
De Backer O; Loupis AM; Ihlemann N; Vejlstrup NG; Søndergaard L; Franzen OW
Dan Med J; 2014 Aug; 61(8):A4879. PubMed ID: 25162439
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years.
Wiebe J; Franke J; Lehn K; Hofmann I; Vaskelyte L; Bertog S; Sievert H
JACC Cardiovasc Interv; 2015 Dec; 8(15):1915-1921. PubMed ID: 26738659
[TBL] [Abstract][Full Text] [Related]
19. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation.
Calvo N; Salterain N; Arguedas H; Macias A; Esteban A; García de Yébenes M; Gavira JJ; Barba J; García-Bolao I
Europace; 2015 Oct; 17(10):1533-40. PubMed ID: 25935163
[TBL] [Abstract][Full Text] [Related]
20. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]